3Fujimoto J, Aoki I, Toyoki H, et al. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers [ J ]. Ann Oncol,2002,13 : 1605-1611
4Ozaki I, Mizuta T, Zhao G, et al. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma[ J ]. Cancer Res,2000 ,60 :6519-6525
5Hahne JC, Okuducu AF, Kaminski A, et al. Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth [ J]. Oncogene,2005 ,24 :5384-5388
6Mattot V, Vercamer C, Soncin F, et al. Constitutive expression of the DNA-binding domain of Etsl increases endothelial cell adhesion and stimulates their organization into capillary-like structures [ J ]. Oncogene,2000,19:762-772
7Watanabe D, Takagi H, Suzuma K, et al. Transcription factor Ets-1 mediates ischemia and vascular endothelial growth factor-dependent retinal neovascularization [ J ]. Am J Pathol,2004,164 : 1827-1835
8Fine BA, Valente PT, Feinstein GI, et al. VEGF, flt21, and KDR/flk21 as prognostic indicators in endometrial carcinoma[ J]. Gynecol Oncol,2000,76:33-39
9Pourtier-Manzanedo A, Vercamer C, Van Belle E, et al. Expession of an ETS-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model[ J ]. Oncogene ,2003,22 : 1795-1806
10Jean Bowler, Tait Brian Steele. Steroid derivatives: US,4659516 [P]. 1987-04-21.
